00:11 , Dec 1, 2016 |  BC Week In Review  |  Financial News

Tetra completes venture financing

Tetra raised $5 million in a series A round co-led by Apjohn Group and Grand Angels. Dolby Family Ventures, the Alzheimer’s Drug Discovery Foundation and other private investors participated. The company also converted $2.2 million...
07:00 , Apr 28, 2014 |  BC Week In Review  |  Financial News

ProNAi completes venture financing

ProNAi Therapeutics Inc. , Kalamazoo, Mich.   Business: Cancer   Date completed: 4/21/14   Type: Venture financing   Raised: $59.5 million   Investors: Vivo Capital; Frazier Healthcare; OrbiMed Advisors; Adams Street Partners; RA Capital Management;...
23:57 , Apr 21, 2014 |  BC Extra  |  Financial News

ProNAi raises $59.5 million D round

ProNAi Therapeutics Inc. (Kalamazoo, Mich.) raised $59.5 million in a series D round led by new investor Vivo Capital. New investors Frazier Healthcare Ventures; OrbiMed Advisors; Adams Street Partners; RA Capital Management; Caxton Alternative Management;...
08:00 , Jan 17, 2011 |  BC Week In Review  |  Financial News

ProNAi completes venture financing

ProNAi Therapeutics Inc. , Kalamazoo, Mich.   Business: Cancer   Date completed: 12/28/2010   Type: Venture financing   Raised: $1.7 million   Investors: Apjohn; Michigan Economic Development Corp.; angel investors   Note: The financing is...
08:00 , Dec 24, 2007 |  BioCentury  |  Emerging Company Profile

Corporate Profile

ProNAi Therapeutics Inc. Kalamazoo, Mich. Technology: Single-stranded DNA interfering therapeutic agents Disease focus: Cancer Clinical status: Preclinical Founded: 2004 by Robert Forgey, Neal Goodwin, Don Parfet, Mina Sooch and Eli Thomssen University collaborators: Wayne State...
01:33 , Sep 8, 2006 |  BC Extra  |  Financial News

RenaMed raises $40 million

RenaMed (Lincoln, R.I.) raised $40 million in a mezzanine financing led by TVM Capital and Lurie Investments. New investors MDS Capital; Merlin BioMed Group; and TSC BioVenture Capital were joined by existing investors Apjohn Ventures;...
00:31 , Aug 16, 2006 |  BC Extra  |  Top Story

Intranasal raises $39.1 million

Intranasal Therapeutics (Montvale, N.J.) raised $39.1 million in a series A round led by SV Life Sciences. Burrill & Co.; Tullis-Dickerson; Fidelity Biosciences; Apjohn Ventures; Fort Washington Capital; Commonwealth Seed Capital; and Kentucky Co-Investment Partners...
01:06 , Sep 21, 2005 |  BC Extra  |  Financial News

Kereos raises $19.5 million

Kereos (St. Louis, Mo.) raised $19.5 million in a series B round led by new investors Prolog Ventures; Triathlon; Charter Life Sciences; and existing investor RiverVest Venture Partners. Existing investor Barnes-Jewish Hospital and new investors...
08:00 , Dec 16, 2004 |  BC Extra  |  Company News

ZyStor, Symbiontics metabolic deal

Symbiontics (St. Louis, Mo.) granted ZyStor (Milwaukee, Wis.) exclusive rights to its glycosylation independent lysosomal technology that is designed to improve the delivery of therapeutics for lysosomal storage diseases. ZyStor also raised $8.5 million in...